Ipsen: publications in the Journal of Endocrine Society
(CercleFinance.com) - Ipsen has reported that it has shared new data on rare diseases, a key therapeutic area in which the pharmaceutical company continues to develop, through the publication of eight abstracts in the medical Journal of the Endocrine Society.
They include the results of a one-year study measuring the natural progression of fibrodysplasia ossificans progressiva (FOP) and the impact of heterotopic ossification on patients' physical capacities over time.
Ipsen and its partners have also shared several studies detailing data from research on healthcare cost savings and therapeutic outcomes in the management of acromegaly.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
They include the results of a one-year study measuring the natural progression of fibrodysplasia ossificans progressiva (FOP) and the impact of heterotopic ossification on patients' physical capacities over time.
Ipsen and its partners have also shared several studies detailing data from research on healthcare cost savings and therapeutic outcomes in the management of acromegaly.
Copyright (c) 2020 CercleFinance.com. All rights reserved.